PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
about
Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and reportProstate MRI based on PI-RADS version 2: how we review and reportA Review of Imaging Methods for Prostate Cancer Detection.Role of multiparametric magnetic resonance imaging in early detection of prostate cancerImaging on nodal staging of prostate cancer.[Selected clinically established and scientific techniques of diffusion-weighted MRI. In the context of imaging in oncology].Correlation of Thyroid Imaging Reporting and Data System [TI-RADS] and fine needle aspiration: experience in 1,000 nodulesProstate imaging reporting and data system version 2 (PI-RADS v2): a pictorial reviewZinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostateLesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score.Review of Prostate Imaging Reporting and Data System version 2.Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancerComparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsyRadiogenomic Analysis of Oncological Data: A Technical Survey.Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy.Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate.Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer.An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI: A meta-analysis.Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancerNew advances in focal therapy for early stage prostate cancer.Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy.Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI.Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.Color-coded visualization of magnetic resonance imaging multiparametric maps.Computational imaging reveals shape differences between normal and malignant prostates on MRI.Novel concepts for risk stratification in prostate cancer.
P2860
Q26738622-D4EB7767-1E39-457D-9098-9C188F887BC1Q26747480-E9C9EAB6-CCE3-4AA9-8E09-663A859AEBFBQ26749289-AB31B079-E40E-412E-B075-F398425B0B8CQ26766398-605C4D2D-D302-427C-81FC-E9F17D9EBDE4Q26768765-EE9E1A02-48EF-4BAA-A190-63E2D9EEDE80Q30244033-AA921273-EE04-4474-BFAF-013307D5D1E5Q31039305-FC1C63A2-632A-4555-8CAA-106BC1FBF791Q31117841-DED6751C-37DA-421C-A1C9-BB92AC6D2A5FQ31121589-0F4BF323-A820-4FE2-9472-9121C6C396B0Q31123635-12644A9C-517E-4130-AC89-1E3446E73519Q31127834-11B83D07-CB31-44D0-99FC-5BD8E7EE247AQ31131775-1B0A3067-6170-4415-8705-1C92EC3FAACCQ31137158-FE267358-F9E2-45DD-AD5C-E1CDA25B592DQ31153190-2EA55E42-0CBA-49EC-880E-95A38060BC56Q33591824-98BE3C1A-E832-418F-824D-FDD906154DDCQ33611513-1AC57993-3D72-4440-BF1B-B76F56F6D2BBQ33624662-C91C7A77-4F0F-4602-A90B-6461DE56D019Q33783620-A25C3BE2-6C8C-4421-90E8-03286052A615Q33838513-4E11E72E-7174-4EF1-AF6A-D44C33A9A30EQ33890175-D623C4F0-139C-45DF-BF00-5CC9D3B78BC2Q33890201-11C40CFA-02D5-4DA5-B49D-5EAC22174FE1Q35952787-267E9C66-DD2F-4531-BFE0-4019C0EB4588Q35953470-733120A6-413E-4770-93D9-6232A3B26422Q36100707-763FF161-6E36-421A-9D13-89116AEFBAC0Q36196197-4BCA0F9B-A6D6-4891-A5FE-10CB1A89C0FCQ36219426-951849E6-C8FA-4CFE-8073-1D4AF70B703EQ36235443-67AA3D18-DAB6-4D18-BADD-7C22E6551659Q36281247-DE89CD3A-733C-4999-A7A9-40A1F92AE7E7Q36364446-4C2BE0E6-A14E-4B20-86B1-B7387BD44F96Q36411076-85D671EC-2D2A-4A16-8F21-D808A49F9D04Q36946259-552C3A03-3D7A-4DC3-AFE6-F39C7A35C989Q37043970-C0729AFF-E556-441B-A9E8-ACDA20B71AABQ37368258-257E1D75-8881-4728-B88D-ABF715624B01Q37368378-4F1CE077-1561-4B0C-A0BA-736E6073CC09Q37390674-BE82F80F-7284-4F19-A98D-8784DDE7849CQ37406144-FA02A16E-F6E7-4E85-AD00-45E7B4996364Q37541876-CFCCE52D-97FD-49B6-877A-47AF5B0F98B8Q37598884-96873A2F-A575-4624-899E-9C466D65EF0DQ37618298-23C284A9-7517-4FBA-BCC6-E340A0A206FCQ37708177-E17D43C8-31CD-4831-AF6C-B44E327F1B58
P2860
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@ast
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@en
type
label
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@ast
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@en
prefLabel
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@ast
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
@en
P2093
P3181
P1433
P1476
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
@en
P2093
Clare M Tempany
Daniel Margolis
Faina Shtern
Francois Cornud
Harriet C Thoeny
Jeffrey C Weinreb
Jelle O Barentsz
Katarzyna J Macura
Masoom A Haider
Mitchell D Schnall
P3181
P356
10.1016/J.EURURO.2015.08.052
P407
P577
2015-10-01T00:00:00Z